Clinical Trial Update: A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BMN 111 in children with achondroplasia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• BMN-111 (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Achondroplasia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15